New Providence, NJ, United States of America

Peter J Connolly

USPTO Granted Patents = 70 

 

 

Average Co-Inventor Count = 4.9

ph-index = 10

Forward Citations = 498(Granted Patents)


Inventors with similar research interests:


Location History:

  • Morristown, NJ (US) (1992 - 1994)
  • Simi Valley, CA (US) (1994)
  • Camarillo, CA (US) (1996 - 2001)
  • Providence, RI (US) (2022)
  • Spring House, PA (US) (2014 - 2023)
  • New Providence, NJ (US) (1995 - 2024)

Company Filing History:


Years Active: 1992-2024

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Pyrazole Derivatives
MALT1 Inhibitors
Cyclic Dinucleotides
STING Agonists
Androgen Receptor Antagonists
FASN Inhibitors
Monoacylglycerol Lipase Inhibitors
Delta Opioid Receptor Modulators
Pyrimidine Compounds
Kinase Inhibitors
ORL-1 Receptor Modulators
Thiazolo [4,5-d]pyrimidines
70 patents (USPTO):Explore Patents

Title: The Innovative Mind of Peter J Connolly in Pharmaceutical Research

Introduction: Peter J Connolly, a prolific inventor based in New Providence, NJ, has made significant contributions to the field of pharmaceutical research. With an impressive portfolio of 70 patents, his work focuses on developing innovative compounds and methods for treating diverse medical conditions. His inventions reflect a commitment to advancing healthcare through scientific ingenuity.

Latest Patents: Among Peter’s notable recent patents are groundbreaking compounds targeting critical biological pathways. One of his latest inventions, related to pyrazole derivatives as MALT1 inhibitors, encompasses novel compounds, compositions, and methods aimed at treating diseases that benefit from the modulation of the MALT1 protein. The compounds described are represented by Formula (I), where various substituents such as R, G, and others are defined.

Another significant patent involves cyclic dinucleotides as STING agonists, which include compounds, compositions, and methods for managing diseases modulated by STING. Similar to the previous patent, these compounds are represented by Formula (I), with distinct chemical definitions outlined for R, R', X, and further substituents.

Career Highlights: Peter's career is marked by his tenure at prominent companies in the pharmaceutical industry, including Janssen Pharmaceutica and Ortho-McNeil Pharmaceutical Corporation. His efforts in these organizations have led to key advancements in drug discovery and therapeutic development, solidifying his reputation as a leading innovator in his field.

Collaborations: Throughout his career, Peter J Connolly has collaborated with esteemed colleagues such as Steven A Middleton and Gilles C Bignan. These partnerships have enabled the exchange of ideas and expertise, fostering an environment of creativity and innovation within the pharmaceutical sector.

Conclusion: Peter J Connolly exemplifies the pioneering spirit in pharmaceutical innovations, contributing immensely through his patents and collaborative efforts. His work continues to have a lasting impact on the treatment of various health conditions, and his legacy as an inventor will inspire future generations in the field of medical research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…